APIXABAN SANDOZ 2.5 mg FILM-COATED TABLETS

Introduction

Package Leaflet: Information for the User

Apixaban Sandoz 2.5 mg film-coated tablets EFG

apixaban

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

• Keep this leaflet, you may need to read it again.
• If you have any further questions, ask your doctor, pharmacist, or nurse.
• This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
• If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack:

1. What is Apixaban Sandoz and what is it used for
2. What you need to know before you take Apixaban Sandoz
3. How to take Apixaban Sandoz
4. Possible side effects
5. How to store Apixaban Sandoz
6. Contents of the pack and other information

1. What is Apixaban Sandoz and what is it used for

This medicine contains the active substance apixaban and belongs to a group of medicines called anticoagulants. This medicine helps to prevent the formation of blood clots by blocking Factor Xa, an important component of blood clotting.

This medicine is used in adults:

• to prevent the formation of blood clots (deep vein thrombosis [DVT]) after hip or knee replacement surgery. After hip or knee replacement surgery, you may have a higher risk of forming blood clots in the veins of your legs. This can cause swelling in your legs, with or without pain. If a blood clot travels from your leg to your lungs, it can block the flow of blood, causing difficulty breathing, with or without chest pain. This medical condition (pulmonary embolism) can be life-threatening and requires immediate medical attention.

• to prevent the formation of a blood clot in the heart in patients with an irregular heartbeat (atrial fibrillation) and at least one additional risk factor. Blood clots can break loose, travel to the brain, and cause a stroke, or travel to other organs, preventing proper irrigation of the organ (also known as systemic embolism). A stroke can be life-threatening and requires immediate medical attention.

• to treat blood clots in the veins of the legs (deep vein thrombosis) and in the blood vessels of the lungs (pulmonary embolism), and to prevent these blood clots from recurring in the blood vessels of the legs and/or lungs.

2. What you need to know before you take Apixaban Sandoz

Do not take Apixaban Sandoz if:

• you are allergicto apixaban or any of the other ingredients of this medicine (listed in section 6),
• you have excessive bleeding,
• you have a disease in an organof the body that increases the risk of severe bleeding (such as an active or recent stomach or intestinal ulcer, or recent brain hemorrhage),
• you have a liver diseasethat increases the risk of bleeding (hepatic coagulopathy),
• you are taking medicines to prevent blood clotting(e.g., warfarin, rivaroxaban, dabigatran, or heparin), except when switching treatment, while having an arterial or venous line and being treated with heparin to keep the line open, or when having a tube inserted into a blood vessel (catheter ablation) to treat an irregular heartbeat (arrhythmia).

Warnings and precautions

Tell your doctor, pharmacist, or nurse before starting to take this medicine if you have any of these conditions:

• an increased risk of bleeding, such as:
• • bleeding disorders, including situations that result in a decrease in platelet activity,
  • very high blood pressure, not controlled by medical treatment,
  • you are over 75 years old,
  • you weigh 60 kg or less,
• severe kidney disease or if you are on dialysis,
• a liver problem or history of liver problems.

This medicine will be used with caution in patients with signs of altered liver function,

• you have had a catheter or received an injection in the spine(for anesthesia or pain relief), your doctor will tell you to wait at least 5 hours after removing the catheter before taking this medicine,
• you have a heart valve prosthesis,
• if your doctor determines that your blood pressure is unstable or you are scheduled to receive another treatment or undergo surgery to remove the blood clot from your lungs.

Be careful with apixaban

• if you know you have a disease called antiphospholipid syndrome(an immune system disorder that increases the risk of forming blood clots), inform your doctor to decide if it may be necessary to modify the treatment.

If you need to have surgery or a procedure that may cause bleeding, your doctor will tell you to temporarily stop taking this medicine for a while. If you are not sure if a procedure may cause bleeding, ask your doctor.

Children and adolescents

This medicine is not recommended for children and adolescents under 18 years of age.

Other medicines and Apixaban Sandoz

Tell your doctor, pharmacist, or nurse if you are using, have recently used, or might use other medicines.

Some medicines may increase the effects of apixaban, and some medicines may decrease its effects. Your doctor will decide if you should be treated with apixaban if you are taking these medicines and if you should be kept under closer observation.

The following medicines may increase the effects of apixaban and increase the possibility of unwanted bleeding:

• some medicines for fungal infections(e.g., ketoconazole, etc.),
• some antiviral medicines for HIV/AIDS(e.g., ritonavir),
• other medicines to reduce blood clotting(e.g., enoxaparin, etc.),
• anti-inflammatoryor pain-relieving medicines(e.g., acetylsalicylic acid or naproxen). Especially if you are over 75 years old and taking acetylsalicylic acid, there is a higher likelihood of bleeding,
• medicines for high blood pressure or heart problems(e.g., diltiazem),
• antidepressantscalled selective serotonin reuptake inhibitorsor serotonin-norepinephrine reuptake inhibitors.

The following medicines may reduce the ability of apixaban to prevent blood clot formation.

• medicines for the treatment of epilepsy or convulsions(e.g., phenytoin, etc.),
• St. John's Wort(a herbal medicine for the treatment of depression),
• medicines for the treatment of tuberculosisor other infections(e.g., rifampicin).

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

The effects of this medicine on pregnancy and the fetus are not known. You should not take this medicine if you are pregnant. Tell your doctor immediatelyif you become pregnant while taking this medicine.

It is not known whether this medicine is excreted in human milk. Ask your doctor or pharmacist for advice before taking this medicine during breastfeeding. They will tell you whether to stop breastfeeding or whether to stop or not start taking this medicine.

Driving and using machines

Apixaban has no influence on the ability to drive or use machines.

Apixaban Sandoz contains lactose (a type of sugar) and sodium

If your doctor has told you that you have an intolerance to some sugars, consult with them before taking this medicine.

This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is, essentially, “sodium-free”.

3. How to take Apixaban Sandoz

Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. In case of doubt, ask your doctor, pharmacist, or nurse.

Dosage

Take the tablet with water. Apixaban can be taken with or without food.

Try to take the tablets at the same time every day to achieve a better effect of the treatment.

If you have difficulty swallowing the tablet whole, talk to your doctor about other possible ways to take apixaban. The tablet can be crushed and mixed with water, 5% glucose in water, apple juice, or apple puree, immediately before taking it.

Instructions for crushing:

• Crush the tablets with a mortar.
• Transfer all the powder carefully into a suitable container, mixing the powder with a small amount, e.g., 30 ml (2 tablespoons), of water or any of the liquids mentioned to make the mixture.
• Take the mixture.
• Rinse the mortar and the mortar's hand that have been used to crush the tablet and the container, with a small amount of water or one of the other liquids (e.g., 30 ml), and take that liquid.

If necessary, your doctor may also administer the crushed apixaban tablet mixed in 60 ml of water or 5% glucose in water, through a nasogastric tube.

Take Apixaban Sandoz according to the following recommendations:

For preventing the formation of blood clots in hip or knee replacement surgery

The recommended dose of apixaban is one 2.5 mg tablet twice a day.

E.g., take one tablet in the morning and one in the evening.

You should take the first tablet between 12 to 24 hours after surgery.

If you have had hipreplacement surgery, you will usually take the tablets for a period of 32 to 38 days.

If you have had kneereplacement surgery, you will usually take the tablets for a period of 10 to 14 days.

For preventing the formation of a blood clot in the heart in patients with an irregular heartbeat and at least one additional risk factor

The recommended dose of apixaban is one 5 mgtablet twice a day.

The recommended dose of apixaban is one 2.5 mgtablet twice a day if:

• you have severely reduced kidney function
• two or more of the following factors apply to you:
• • your blood test results suggest poor kidney function(the serum creatinine value is 1.5 mg/dl (133 micromoles/l) or higher),
  • you are 80 years old or older,
  • your weight is 60 kg or less.

The recommended dose is one tablet twice a day, e.g., take one tablet in the morning and one in the evening.

Your doctor will tell you how long you should continue the treatment.

For treating blood clots in the veins of the legs and in the blood vessels of the lungs

The recommended dose of apixaban is two 5 mg tabletstwice a day for the first 7 days, e.g., two tablets in the morning and two tablets in the evening.

After 7 days, the recommended dose of apixaban is one 5 mg tablettwice a day, e.g., one tablet in the morning and one in the evening.

For preventing the recurrence of blood clots after 6 months of treatment

The recommended dose of apixaban is one 2.5 mgtablet twice a day, e.g., one tablet in the morning and one in the evening.

Your doctor will tell you how long you should continue the treatment.

Your doctor may change your anticoagulant treatment as follows:

Switching from Apixaban Sandoz to other anticoagulant medicines

Stop taking Apixaban Sandoz. Start treatment with other anticoagulant medicines (e.g., heparin) at the time you would have taken the next Apixaban Sandoz tablet.

Switching from other anticoagulant medicines to Apixaban Sandoz

Stop taking other anticoagulant medicines. Start treatment with Apixaban Sandoz at the time you would have taken the next dose of the other anticoagulant medicine, and then continue as usual.

Switching from treatment with anticoagulants that contain Vitamin K antagonists (e.g., warfarin) to Apixaban Sandoz

Stop taking the medicine that contains a Vitamin K antagonist. Your doctor will need to perform blood tests and tell you when to start taking Apixaban Sandoz.

Switching from Apixaban Sandoz to treatment with anticoagulants that contain Vitamin K antagonists (e.g., warfarin)

If your doctor tells you to start taking a medicine that contains a Vitamin K antagonist, continue taking Apixaban Sandoz for at least 2 days after your first dose of the medicine that contains a Vitamin K antagonist. Your doctor will need to perform blood tests and tell you when to stop taking Apixaban Sandoz.

Patients undergoing cardioversion

If your heartbeat needs to be restored through a process called cardioversion, take this medicine at the times your doctor tells you to prevent blood clots in the blood vessels of the brain and other blood vessels in the body.

If you take more Apixaban Sandoz than you should

Tell your doctor immediatelyif you have taken a dose higher than the prescribed dose of this medicine. Take the package of the medicine to your doctor, even if there are no tablets left.

If you take more Apixaban Sandoz than the recommended dose, you may increase the risk of bleeding. If bleeding occurs, surgery, blood transfusions, or other treatments that can reverse the anti-factor Xa activity may be necessary.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount taken.

If you forget to take Apixaban Sandoz

Take the dose as soon as you remember and:

• take the next dose of apixaban at the usual time,
• then continue taking the medicine as usual.

If you are unsure what to do or if you forget to take more than one dose, ask your doctor, pharmacist, or nurse.

If you stop taking Apixaban Sandoz

Do not stop taking this medicine without talking to your doctor first, because the risk of developing a blood clot may be higher if you stop the treatment too soon.

If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or nurse.

4. Possible Adverse Effects

Like all medicines, this medicine can cause adverse effects, although not all people suffer from them. Apixaban can be administered for three different diseases. The known adverse effects and the frequency with which they occur may be different and are therefore indicated separately below. For these conditions, the most frequent adverse effect of this medicine is bleeding, which can put the patient's life at risk and requires immediate medical attention.

The following adverse effects have been reported when taking apixaban to prevent the formation of blood clots in hip or knee replacement surgery.

Frequent Adverse Effects (may affect up to 1 in 10 people)

• Anemia, which can cause fatigue or paleness.
• Bleeding, including:
• • hematoma and swelling.
• Nausea (general feeling of discomfort).

Uncommon Adverse Effects (may affect up to 1 in 100 people)

• Decrease in the number of platelets in the blood (which can affect coagulation).
• Bleeding:
• • after an operation, including hematoma and swelling, blood or fluid secretion from the wound/surgical incision (suppuration), or injection site,
  • from the stomach, intestine, or blood in the stool,
  • blood in the urine,
  • from the nose,
  • vaginal,
• Low blood pressure, which can cause fainting or a faster heart rate.
• Blood tests may show:
• • abnormal liver function,
  • increase in some liver enzymes,
  • increase in bilirubin, a product derived from red blood cells, which can cause yellowing of the skin and eyes.
• Itching.

Rare Adverse Effects (may affect up to 1 in 1,000 people)

• Allergic reactions (hypersensitivity) that can cause: swelling of the face, lips, mouth, tongue, and/or throat, and difficulty breathing. Inform your doctor immediatelyif you experience any of these symptoms.
• Bleeding:
• • in a muscle,
  • in the eyes,
  • from the gums and coughing up blood,
  • from the rectum,
• Hair loss.

Frequency Not Known (cannot be estimated from available data)

• Bleeding:
• • in the brain or spinal cord,
  • in the lungs or throat,
  • in the mouth,
  • in the abdomen or the space behind the abdominal cavity,
  • hemorrhoidal,
  • tests showing blood in the stool or urine.
• Skin rash that can form blisters and resemble small targets (dark spots in the center surrounded by a paler area, with a dark ring around) (erythema multiforme).
• Inflammation of the blood vessels (vasculitis) that can cause skin rash or pinpoint, flat, red, and round spots under the skin surface or bruises.

The following adverse effects have been reported when taking apixaban to prevent the formation of blood clots in the heart in patients with irregular heart rhythm and at least one additional risk factor.

Frequent Adverse Effects (may affect up to 1 in 10 people)

• Bleeding, including:
• • in the eyes,
  • in the stomach or intestine,
  • from the rectum,
  • blood in the urine,
  • from the nose,
  • from the gums,
  • hematoma and swelling,
• Anemia, which can cause fatigue or paleness.
• Low blood pressure, which can cause fainting or a faster heart rate.
• Nausea (general feeling of discomfort).
• Blood tests may show:
• • an increase in gamma glutamyl transferase (GGT).

Uncommon Adverse Effects (may affect up to 1 in 100 people)

• Bleeding:
• • in the brain or spinal cord,
  • in the mouth or coughing up blood,
  • in the abdomen, or vagina,
  • bright/red blood in the stool,
  • bleeding after surgery, including hematoma and swelling, blood or fluid secretion from the wound/surgical incision (suppuration) or injection site,
  • hemorrhoidal,
  • tests showing blood in the stool or urine.
• Decrease in the number of platelets in the blood (which can affect coagulation).
• Blood tests may show:
• • abnormal liver function,
  • increase in some liver enzymes,
  • increase in bilirubin, a product derived from red blood cells, which can cause yellowing of the skin and eyes.
• Skin rash.
• Itching.
• Hair loss.
• Allergic reactions (hypersensitivity) that can cause: swelling of the face, lips, mouth, tongue, and/or throat, and difficulty breathing. Inform your doctor immediatelyif you experience any of these symptoms.

Rare Adverse Effects (may affect up to 1 in 1,000 people)

• Bleeding:
• • in the lungs or throat,
  • in the space behind the abdominal cavity,
  • in a muscle.

Very Rare Adverse Effects (may affect up to 1 in 10,000 people)

• Skin rash that can form blisters and resemble small targets (dark spots in the center surrounded by a paler area, with a dark ring around) (erythema multiforme).

Frequency Not Known (cannot be estimated from available data)

• Inflammation of the blood vessels (vasculitis) that can cause skin rash or pinpoint, flat, red, and round spots under the skin surface or bruises.

The following adverse effects have been reported when taking apixaban to treat or prevent blood clots from recurring in the veins of the legs and in the blood vessels of the lungs.

Frequent Adverse Effects (may affect up to 1 in 10 people)

• Bleeding, including:
• • from the nose,
  • from the gums,
  • blood in the urine,
  • hematoma and swelling,
  • in the stomach, intestine, or rectum,
  • in the mouth,
  • vaginal,
• Anemia, which can cause fatigue or paleness.
• Decrease in the number of platelets in the blood (which can affect coagulation).
• Nausea (general feeling of discomfort).
• Skin rash.
• Blood tests may show:
• • an increase in gamma glutamyl transferase (GGT) or alanine aminotransferase (ALT).

Uncommon Adverse Effects (may affect up to 1 in 100 people)

• Low blood pressure, which can cause fainting or a faster heart rate.
• Bleeding:
• • in the eyes,
  • in the mouth or coughing up blood,
  • bright/red blood in the stool,
  • tests showing blood in the stool or urine,
  • bleeding after surgery, including hematoma and swelling, blood or fluid secretion from the wound/surgical incision (suppuration) or injection site;
  • hemorrhoidal,
  • in a muscle,
• Itching.
• Hair loss.
• Allergic reactions (hypersensitivity) that can cause: swelling of the face, lips, mouth, tongue, and/or throat, and difficulty breathing. Inform your doctor immediatelyif you experience any of these symptoms.
• Blood tests may show:
• • abnormal liver function,
  • increase in some liver enzymes,
  • increase in bilirubin, a product derived from red blood cells, which can cause yellowing of the skin and eyes.

Rare Adverse Effects (may affect up to 1 in 1,000 people)

• Bleeding:
• • in the brain or spinal cord,
  • in the lungs.

Frequency Not Known (cannot be estimated from available data)

• Bleeding:
• • in the abdomen or the space behind the abdominal cavity.
• Skin rash that can form blisters and resemble small targets (dark spots in the center surrounded by a paler area, with a dark ring around) (erythema multiforme).
• Inflammation of the blood vessels (vasculitis) that can cause skin rash or pinpoint, flat, red, and round spots under the skin surface or bruises.

Reporting Adverse Effects

If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.

5. Storage of Apixaban Sandoz

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiration date that appears on the packaging and on each blister, after "CAD/EXP". The expiration date is the last day of the month indicated.

This medicine does not require special storage conditions

Medicines should not be thrown away through wastewater or household waste. Deposit the packaging and medicines you no longer need in the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.

6. Package Contents and Additional Information

Composition of Apixaban Sandoz

• The active ingredient is apixaban. Each film-coated tablet contains 2.5 mg of apixaban.
• The other ingredients are:
• • Core of the tablet: lactose monohydrate, microcrystalline cellulose, sodium croscarmellose, sodium lauryl sulfate, magnesium stearate.
  • Coating: hypromellose, hydroxypropylcellulose, macrogol 6000, titanium dioxide (E171), yellow iron oxide (E172).

See section 2 "Apixaban Sandoz contains lactose (a type of sugar) and sodium".

Appearance of the Product and Package Contents

Apixaban Sandoz 2.5 mg are film-coated tablets (tablets) yellow, round, biconvex, engraved with "AX" on one side and with "2.5" on the other side, with a diameter of 5.7 - 6.5 mm.

The product is available in:

Alu-PVC/PVdC blisters in packs of 10, 12, 14, 20, 28, 30, 56, 60, 100, 168, 180, and 200 film-coated tablets.

Perforated unit-dose Alu-PVC/PVdC blisters in packs of 20x1, 60x1, 100x1, and 168x1 film-coated tablets.

HDPE/PP bottle of 200 film-coated tablets.

Not all pack sizes may be marketed.

Patient Information Card: Information Management

Inside the Apixaban Sandoz packaging, along with the prospectus, you will find a Patient Information Card or your healthcare professional may give you a similar card.

This Patient Information Card includes useful information for you and will alert other doctors that you are being treated with Apixaban Sandoz. You must keep this card with you at all times.

1. Take the card
2. Complete the following sections or ask your doctor to complete them:

• Name:
• Date of birth:
• Indication:
• Dose: ......mg twice a day
• Doctor's name:
• Doctor's phone number:
• 1. Fold the card and carry it with you at all times

Marketing Authorization Holder and Manufacturer

Marketing Authorization Holder

Sandoz Farmacéutica, S.A.

Centro Empresarial Parque Norte

Edificio Roble

C/ Serrano Galvache, 56

28033 Madrid

Spain

Manufacturer

Lek Pharmaceuticals d.d.

Verovskova ulica 57

1526 Ljubljana

Slovenia

or

Lek S.A.

Ul. Podlipie 16

95 010 Strykow

Poland

This medicine is authorized in the Member States of the European Economic Area and in the United Kingdom (Northern Ireland) under the following names:

Netherlands: Apixaban Sandoz 2,5 mg, filmomhulde tabletten

Austria: Apixaban Sandoz 2,5 mg – Filmtabletten

Belgium: Apixaban Sandoz 2,5 mg filmomhulde tabletten

Czech Republic: Apixaban Sandoz

Denmark: Apixaban Sandoz

Greece: Apixaban/Sandoz F.C. TAB 2,5 mg

Finland: Apixaban Sandoz

France: APIXABAN SANDOZ 2.5 mg, comprimé pelliculé

Hungary: Apixaban Sandoz 2,5 mg filmtabletta

Ireland: Apixaban Rowex 2.5 mg film-coated tablets

Iceland: Apixaban Sandoz

Italy: Apixaban Sandoz

Norway: Apixaban Sandoz

Portugal: Apixaban Sandoz

Sweden: Apixaban Sandoz

Slovakia: Apixaban Sandoz 2,5 mg

United Kingdom (Northern Ireland): Apixaban Sandoz 2.5 mg Film coated tablets

Date of the last revision of this prospectus: February 2024

Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/